Arrowstreet Capital
ENZN

Arrowstreet Capital’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Arrowstreet Capital’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-115,380
Closed -$54K – 1653
2016
Q1 		$54K Hold
115,380
– – ﹤0.01% 1298
2015
Q4 		$79K Hold
115,380
– – ﹤0.01% 1362
2015
Q3 		$112K Hold
115,380
– – ﹤0.01% 1303
2015
Q2 		$138K Hold
115,380
– – ﹤0.01% 1139
2015
Q1 		$122K Hold
115,380
– – ﹤0.01% 954
2014
Q4 		$126K Hold
115,380
– – ﹤0.01% 1196
2014
Q3 		$125K Buy
+115,380
New +$142K ﹤0.01% 957

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Arrowstreet Capital's ENZN Position: Q2 2016 in Review

Arrowstreet Capital sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 115,380 shares — an estimated $54K sold.

Arrowstreet Capital first reported a position in ENZN in Q3 2014 and held it in 7 quarters. The position peaked at $138K in Q2 2015. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Arrowstreet Capital reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Arrowstreet Capital sold 115,380 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $54K.
  • Arrowstreet Capital first reported a position in ENZON PHARMACEUTICALS INC in Q3 2014 and held it in 7 quarters.
  • Arrowstreet Capital's ENZON PHARMACEUTICALS INC position peaked at $138K in Q2 2015.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Arrowstreet Capital's 13F filing for Q2 2016, filed 15 Aug 2016.